◆英語タイトル:Hyaluni -Drug Insights, 2016
◆レポート形式:英語 / PDF
Single User(1名使用)USD1,000 ⇒換算¥106,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,000 ⇒換算¥212,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD3,000 ⇒換算¥318,000見積依頼/購入/質問フォーム



DelveInsight Drug Report, “Hyaluni- Drug Insights, 2016” highlights the Hyaluni marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Hyaluni covering the total sales estimation and also provides the Hyaluni sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Hyaluni, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Hyaluni.
Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

• A review of the Hyaluni based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Hyaluni on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Hyaluni with location details
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Global Forecasted Sales Figure to 2018
• Qualitative and quantitative assessment of market space
• SWOT Analysis


Table of Contents

1. DelveInsight Report Introduction
2. Hyaluni Overview
2.1 Market Competition
2.3 Competitors in Development
3 Global Sales Assessment
3.1 Historical Sales of Somavert
3.2 Forecasted Sales of Somavert
4 Product Description
4.1 Mechanism of Action
4.2 Pharmacodynamic Properties
4.3 Pharmacokinetic Properties
5 Marketed Details
5.1 United States
5.2 Europe
6 Patent Information
6.1 Patent Numbers and Expiry Details
6.2 Patent and Exclusivity Expiry Assessment United States (US)
6.3 Patent Details
7 Route of Synthesis
8 Global API Manufacturers Assessment
8.1 The United States Drug Master File (US DMF)
8.2 The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China
8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India
9 Generic Players
10 The Pipeline Coverage
11 Clinical Trials Information
11.1 Clinical Trials by Zone
12 Company Profile
12.1 Company Summary
12.2 Company Financials
13 SWOT Analysis
14 References
15 Appendix
16 Methodology
17 Consulting Services
18 About DelveInsight
19 Contact Us
20 Disclaimer

List of Tables
• Table 1: Hyaluni, Historical Global Sales (in million USD), 2016
• Table 2: Hyaluni, Forecasted Global Sales (in million USD), 2016
• Table 3: Hyaluni, Description
• Table 4: Hyaluni, Marketed Details the United States (US)
• Table 5: Hyaluni, Marketed Details the Europe (EU)
• Table 6: Hyaluni, Patent/Exclusivity Expiry (Year), 2016
• Table 7: Hyaluni, Patent Number Specific Patent Expiry (Year), 2016
• Table 8: Hyaluni, Patent Details
• Table 9: Hyaluni, Route of Synthesis
• Table 10: Hyaluni, the United States Drug Master File (US DMF), 2016
• Table 11: Hyaluni, the Europe Active Substance Master File (ASMF), 2016
• Table 12: Hyaluni, the API Manufacturers, China, 2016
• Table 13: Hyaluni, the API Manufacturers, India, 2016
• Table 14: Hyaluni, Generic Players, 2016
• Table 15: Hyaluni, Pipeline Drug Details, 2016
• Table 16: Hyaluni, Clinical Trials, 2016
• Table 17: Hyaluni, Clinical Trials by Zone, 2016
• Table 18: Company Overview, 2016
• Table 19: Hyaluni, SWOT Analysis, 2016

List of Figures
• Figure 1: Hyaluni, Historical Global Sales (in million USD), 2016
• Figure 2: Hyaluni, Forecasted Global Sales (in million USD), 2016
• Figure 3: Hyaluni, Patent/Exclusivity Expiry (Year), 2016
• Figure 4: Hyaluni, Patent Number Specific Patent Expiry (Year), 2016
• Figure 5: Hyaluni, Route of synthesis
• Figure 6: Hyaluni, the API Manufacturers by the US DMF Status (%), 2016
• Figure 7: Hyaluni, the API Manufacturers by Region, 2016
• Figure 8: Hyaluni, the API Manufacturers by Location/Countries, 2016
• Figure 9: Hyaluni, Generic Players, 2016
• Figure 10: Hyaluni, Clinical Trials by Zone (%), 2016




★リサーチレポート[ Hyaluni:医薬品の世界市場2016(Hyaluni -Drug Insights, 2016)]についてメールでお問い合わせはこちらでお願いします。